Castrate Resistant Prostate Cancer (CRPC) is an advanced disease resistant to systemic traditional medical or surgical castration, and resistance is primarily attributed to reactivation of AR through multiple mechanisms. | TMPRSS2-ERG fusions confer efficacy of enzalutamide in an in vivo bone tumor growth model